Digital Health Startups

Mellitus Health develops FDA-cleared decision-support software that helps clinicians optimize insulin dosing for diabetes patients by analyzing glucometer readings and providing patient-specific dosage adjustments. The platform is designed for primary care providers managing insulin therapy in clinical settings.

2 investors

Memed operates a digital prescription platform in Brazil that connects physicians, patients, pharmacies, pharmaceutical companies, and health institutions. It digitizes the medical prescription process and provides data-driven market intelligence and clinical insights across the healthcare ecosystem.

2 investors

Menda Health develops digital health solutions grounded in modern pain science, working with board-certified physicians and specialists to address chronic pain conditions like back pain, sciatica, and migraines.

2 investors

Meomind provides personalized, evidence-based psychotherapy accessible on demand 24/7 through digital platforms. The company targets individuals seeking mental health support and aims to scale therapy access globally at affordable rates.

2 investors

DARA's Result Interpretation Module provides a digitalized workflow that replaces manual document handling processes for specialists, eliminating printing, scanning, email distribution, and courier services in healthcare result management.

2 investors

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures. The company advances agonist antibody programs and operates a RAFT target discovery platform to identify new therapeutic targets.

2 investors

Metabolomic Diagnostics develops diagnostic tests using mass spectrometry and biomarker analysis, with a focus on women's health and pregnancy-related diseases. The company serves clinical laboratories and healthcare professionals through analytical innovation and diagnostic assay development.

2 investors

Methinks develops artificial intelligence software modules that detect acute stroke conditions (large vessel occlusions and intracranial hemorrhages) from medical imaging scans for hospital stroke teams. The products are integrated within Microsoft Teams to streamline clinical workflow and patient care coordination.

2 investors

Mevo is a Brazilian health platform that offers digital prescription management and online medication ordering and delivery services. The platform integrates with hospitals, clinics, telemedicine providers, and pharmacies to simplify healthcare workflows for patients, doctors, and pharmacists.

2 investors

MFine provides an app-based corporate healthcare platform offering doctor consultations, diagnostic tests, and OPD benefits, with wallet-based cashless spending. It targets employers and HR teams who configure and monitor healthcare benefits for their workforce.

2 investors

MICIN Inc. is a Japanese company operating in healthcare, publishing disclosures about funding provided to medical institutions in line with industry transparency guidelines. This page is a regulatory/transparency disclosure rather than a product description.

2 investors

Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.

2 investors

Microgenesis offers a science-based, functional wellness program focused on reproductive health and fertility, analyzing factors such as inflammation, gut health, metabolism, stress, and physical activity. It provides an initial free assessment, personalized consultations to interpret results, and a 90-day plan for individuals working toward pregnancy.

2 investors

miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.

2 investors

Mign designs custom orthopedic braces using digital technology and local manufacturing, replacing mass-produced solutions with personalized care for patients and healthcare providers.

2 investors

Mika Health provides AI-powered patient triage and appointment booking solutions for clinics and healthcare practices. The platform enables patients to request and book appointments through a conversational chatbot interface that integrates directly with clinic EMR systems, while also offering complementary AI scribe and patient reminder features.

2 investors

Minacolor (株式会社ミナカラ) operates an online health service in Japan that provides information about over-the-counter medicines and self-medication, drawing on data from the Self-Medication Database Center. It also offers information about medical institutions to consumers.

2 investors

Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology. The company operates in the digital health and diagnostics space.

2 investors

Mindframe builds AI-powered technology for behavioral health practitioners to enhance clinical care delivery and patient engagement in regulated healthcare environments. The platform is designed for mental health clinics, hospitals, and health systems.

2 investors

Mindler provides digital mental health care, offering online psychological treatment through a network of clinicians serving patients across multiple countries. It operates in the digital health and mental health sector.

2 investors

MindMate is a mobile app that supports caregivers and individuals with cognitive decline through brain games, nutrition guidance, exercise, and social interaction features. The app helps users document memories and maintain engagement while managing symptoms of dementia and Alzheimer's.

2 investors

MindMaze develops neurotherapeutic solutions combining behavioral therapy, software, devices, and data to treat and manage neurological disease and support brain health and recovery. Its precision neurotherapeutic products are used by patients and caregivers in clinical centers worldwide.

2 investors

Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.

2 investors

MindRhythm develops a portable, non-invasive medical device that uses the Headpulse algorithm and AI to triage stroke patients in the prehospital setting, helping paramedics identify Large Vessel Occlusion strokes and route patients to appropriate hospitals faster. The company targets emergency and neurological care providers in the stroke diagnostics market.

2 investors